zolmitriptan 2.5 MG/ACTUAT Nasal Spray

RxCUI: 1483677
RxNorm name: zolmitriptan 2.5 MG/ACTUAT Nasal Spray
Display name: zolmitriptan 2.5 MG/ACTUAT Nasal Spray
Full name: zolmitriptan 2.5 MG/ACTUAT Nasal Spray
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Zolmitriptan	ZOLMITRIPTAN	Amneal Pharmaceuticals NY LLC	05a40502-149d-41bd-966e-771e937a955b	2019-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 1483677

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2438c223-605b-4885-afc3-a6794f190f89	ZOLMitriptan 2.5 MG/ACTUAT Nasal Spray [PSN] · zolmitriptan 2.5 MG/ACTUAT Nasal Spray [SCD] · zolmitriptan 2.5 MG/0.1 ML Nasal Spray [SY]	3	6	These highlights do not include all the information needed to use ZOMIG Nasal Spray safely and effectively. See full prescribing information for ZOMIG Nasal Spray. ZOMIG ® (zolmitriptan) nasal spray Initial U.S. Approval: 1997	20190404
05a40502-149d-41bd-966e-771e937a955b	ZOLMitriptan 2.5 MG/ACTUAT Nasal Spray [PSN] · zolmitriptan 2.5 MG/ACTUAT Nasal Spray [SCD] · zolmitriptan 2.5 MG/0.1 ML Nasal Spray [SY]	3	5	These highlights do not include all the information needed to use ZOLMITRIPTAN NASAL SPRAY safely and effectively. See full prescribing information for ZOLMITRIPTAN NASAL SPRAY. ZOLMITRIPTAN nasal spray Initial U.S. Approval: 1997	20190430